Scaling up Maternal Health Equity Best Practices
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorMichigan State University
About this trial
This study works with prenatal and postnatal care providers in 12 Michigan counties to scale up best practices for maternal health equity.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
None
Disqualifiers
None
Trial design
Design model
Sequential
Treatments tested in this trial
Services as usual
Other interventionDuring this phase of the stepped wedge design, agencies offering prenatal and postnatal care will follow their standard procedures
Scale-up implementation approach
Other interventionAn implementation approach for scaling up bundled equity-focused maternal health safety guidelines in community care settings county-wide, co-developed with partners. It may involve implementation approaches such as training, facilitation, learning collaboratives, coalitions, and other activities.
Treatment groups
600 Participants
are divided into 2 treatment groupsGroup A: Services as usualActive comparator 1 intervention
Group B: Scale-up implementation approachExperimental treatment 1 intervention
Trial outcomes
Primary outcomes
1
African-American and Hispanic pregnancy-related and associated morbidity and mortality (PRAMM)
A composite variable reflecting all pregnancy-related and associated morbidity and mortality conditions from pregnancy through 12 months postpartum, assessed using Medicaid claims data. The investigators will assess overall rates for African-American/Hispanic people and their rates relative to non-Hispanic white ones.
Time frame
Continuous for 6 yearsSecondary outcomes
1
Scale-up: Penetration
Penetration (% providers/staff using recommended maternal health equity practices)
Time frame
Assessed annually for 6 years2
Scale-up: Reach
Number of perinatal people receiving recommended practices
Time frame
Assessed annually for 6 years3
Scale-up: Control for delivery
The degree to which control for delivery shifts to local actors and the practices are embedded in local delivery systems
Time frame
Assessed annually for 6 years4
Scale-up: Effectiveness
Effectiveness is retained as the intervention is scaled: Operationalized using outcome 1 (PRAMM) analyses.
Time frame
Assessed annually for 6 yearsSponsors and contacts
Click on the lead sponsor to view all of their trials.
Michigan State University
Lead sponsor
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Collaborator
Source ClinicalTrials.gov